APPLIED GENETIC TECHNOL CORP's ticker is AGTC and the CUSIP is 03820J100. A total of 75 filers reported holding APPLIED GENETIC TECHNOL CORP in Q3 2020. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $120,000 | -52.8% | 442,619 | +34.0% | 0.00% | -50.0% |
Q2 2022 | $254,000 | +0.4% | 330,287 | +39.8% | 0.00% | 0.0% |
Q1 2022 | $253,000 | -5.2% | 236,335 | +68.3% | 0.00% | -20.0% |
Q4 2021 | $267,000 | -40.1% | 140,389 | -5.2% | 0.01% | -44.4% |
Q3 2021 | $446,000 | -34.8% | 148,058 | -15.4% | 0.01% | -35.7% |
Q2 2021 | $684,000 | +13.2% | 174,908 | +46.9% | 0.01% | +7.7% |
Q1 2021 | $604,000 | +26.6% | 119,048 | +2.1% | 0.01% | +18.2% |
Q4 2020 | $477,000 | -19.4% | 116,592 | -4.2% | 0.01% | -26.7% |
Q3 2020 | $592,000 | -14.5% | 121,746 | -2.5% | 0.02% | -25.0% |
Q2 2020 | $692,000 | +60.6% | 124,874 | -5.1% | 0.02% | +42.9% |
Q1 2020 | $431,000 | -28.3% | 131,526 | -1.1% | 0.01% | -6.7% |
Q4 2019 | $601,000 | -5.8% | 132,944 | -13.4% | 0.02% | -25.0% |
Q3 2019 | $638,000 | +4.6% | 153,468 | -4.7% | 0.02% | +5.3% |
Q2 2019 | $610,000 | – | 160,975 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Private Capital Advisors, Inc. | 397,882 | $7,954,000 | 2.89% |
DAFNA Capital Management LLC | 109,323 | $2,185,000 | 1.68% |
Ghost Tree Capital, LLC | 233,500 | $4,668,000 | 0.84% |
SPHERA FUNDS MANAGEMENT LTD. | 235,124 | $4,700,000 | 0.49% |
Perceptive Advisors | 301,222 | $6,021,000 | 0.47% |
Eventide Asset Management | 205,500 | $4,108,000 | 0.31% |
Visium Asset Management, LP | 1,000,000 | $19,990,000 | 0.30% |
EverPoint Asset Management, LLC | 511,703 | $10,229,000 | 0.19% |
Lombard Odier Asset Management (USA) Corp | 92,089 | $1,841,000 | 0.15% |
Point72 Asset Management, L.P. | 1,032,000 | $20,630,000 | 0.14% |